Hims & Hers Health Inc. (NYSE:HIMS) closed Thursday at $5.47 per share, down from $5.68 a day earlier. While Hims & Hers Health Inc. has underperformed by -3.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HIMS fell by -33.62%, with highs and lows ranging from $9.19 to $2.72, whereas the simple moving average jumped by 5.42% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
On September 07, 2022, Truist started tracking Hims & Hers Health Inc. (NYSE: HIMS) recommending Hold. A report published by SVB Leerink on July 15, 2022, Initiated its previous ‘Underperform’ rating for HIMS. Guggenheim also rated HIMS shares as ‘Buy’, setting a target price of $10 on the company’s shares in an initiating report dated April 14, 2022. Credit Suisse Initiated an Outperform rating on April 01, 2022, and assigned a price target of $8. Deutsche Bank initiated its ‘Hold’ rating for HIMS, as published in its report on March 10, 2022. Jefferies’s report from December 02, 2021 suggests a price prediction of $7 for HIMS shares, giving the stock a ‘Hold’ rating. Piper Sandler also rated the stock as ‘Overweight’.
Analysis of Hims & Hers Health Inc. (HIMS)
Further, the quarter-over-quarter increase in sales is 87.10%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Hims & Hers Health Inc.’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -24.90% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.80, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and HIMS is recording an average volume of 1.94M. On a monthly basis, the volatility of the stock is set at 5.32%, whereas on a weekly basis, it is put at 4.52%, with a loss of -9.29% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.15, showing growth from the present price of $5.47, which can serve as yet another indication of whether HIMS is worth investing in or should be passed over.
How Do You Analyze Hims & Hers Health Inc. Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.80%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 55.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in HIMS shares?
The recent increase in stakes in HIMS appears to be a result of several institutional investors and hedge funds increasing their positions. The Vanguard Group, Inc.’s position in HIMS has increased by 21.53% in the first quarter. The company now owns 10,938,001 shares of the stock, with a value of $69.57 million, following the purchase of 1,937,761 additional shares during the last quarter. BlackRock Fund Advisors made another increased to its shares in HIMS during the first quarter, upping its stake by 250.80%.
At the end of the first quarter, Marshall Wace LLP increased its HIMS holdings by 102.43% and now holds 2.15 million HIMS shares valued at $13.65 million with the added 1.09 million shares during the period. HIMS shares are owned by institutional investors to the tune of 55.70% at present.